Stem cell-based therapeutics are a fast-growing area of early-stage biotech research, but they need better production methods to enable large-scale R&D.
Stem cells from blood vessels could reduce or even prevent heart damage in people with the inherited muscle-wasting disease Duchenne muscular dystrophy.
In a mouse study of amyotrophic lateral sclerosis, injected neural stem cells moved to the spinal cord and multiplied, extending life span 20 days and improving muscle function 15%.
A cell transplant has restored sight in totally blind mice.
By using stem cell technology, two teams of Japanese researchers have been able to rejuvenate immune cells, pointing to a possible route to boost patients' inbuilt immune responses and allowing them to tackle aggressive onslaughts like HIV infections and cancer.
A consortium of researchers from across the U.S. has taken a step forward in the treatment of amyotrophic lateral sclerosis by transplanting neural stem cells into mice and slowing the paralysis caused by this lethal and incurable neurodegenerative disease.
Using viruses to deliver a single gene, U.S. researchers have reprogrammed heart cells and converted them into working biological pacemakers that could regulate the erratic beating of a failing heart.
U.K. researchers have found a less painful way to source samples to make stem cells, using blood rather than biopsies, and their findings could pave the way to treat cardiovascular disease and rebuild patients' hearts and other organs.
Stem cells derived from skeletal muscle helped improve heart function in rats after a heart attack, according to new research by scientists in Norway.
Scientists at the Texas Biomedical Research Institute have big plans for a new treatment designed to help stop the transmission of HIV. The San Antonio Express-News reports that in January they'll start testing a genetically engineered vaccine in rhesus monkeys that interacts with epithelial stem cells to do its job.